Answer
Yes. Treating bleeding and preventing peri-procedural bleeding in acquired haemophilia are licensed uses.
Sources for this answer
- NovoSeven 2mg (100 KIU) powder and solvent for solution for injection — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.